TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

12-15 November 2019|RAI Amsterdam,Amsterdam, Netherlands

EUROPE’S #1 FORUM FOR OLIGONUCLEOTIDE AND PEPTIDE LEADERS TO BUILD SUCCESSFUL PARTNERSHIPS AND ACCELERATE NEW PRODUCTS TO MARKET

Registration is now closed for TIDES Europe 2019. Onsite registration is available.

Below are the registration hours @ the RAI Amsterdam:

Tuesday, 12 November | 07.30 – 17.00
Wednesday, 13 November | 07.30 – 18.00
Thursday, 14 November | 08.00 – 18.30
Friday, 15 November | 07.30 – 15.30

Any additional questions, please email our customer service team at registrations@informa-ls.com.

Get the latest event updates

Sign up to get the latest event updates and information.

TIDES OFFERS THE SCIENCE, TECHNOLOGIES AND PARTNERS YOU NEED TO GROW YOUR BUSINESS

400+ OLIGONUCLEOTIDE AND PEPTIDE SCIENTISTS AND EXECUTIVES

Fast-track your oligonucleotide and peptide research to the clinic and beyond by collaborating with leading pharma, biotechs, academia and solution providers from North America, Asia and Europe.

See Who Attended TIDES Europe 2018
40+ CASE STUDIES AND NEW DATA PRESENTATIONS

Hear best practices, lessons learned and important industry developments across the entire spectrum of oligonucleotide and peptide development and production.

View the 2019 Agenda
30+ LEADING EXHIBITORS

Connect with leading manufacturing, technologies, and service providers to drive your promising therapeutic towards commercial success.

See Whose Exhibiting at TIDES Europe 2019

Cross-Fertilize Ideas with Different Disciplines at TIDES Europe and Learn from Multiple Case Studies and New Data Presentations

Oligonucleotides
  • Discovery, Preclinical and Clinical Case Studies
  • CMC and Manufacturing Strategies
  • Strategies for Extra-Hepatic Delivery
  • Novel Chemistries
  • Analytical and QC Strategies
  • The Path to a Successful IND/IMPD
Peptides
  • Peptide Lead Discovery and Modulators of Cellular Proteins
  • Discovery, Preclinical and Clinical Case Studies
  • NEW! Peptide CMC and Manufacturing Track
  • Personalized Peptides and Peptide Vaccines
  • Peptide Delivery and Formulations
  • Accelerating Peptides to IND and Beyond
New for 2019
  • Expanded mRNA Therapeutic & CRISPR/Cas Content
  • New Focus on Delivery of Macromolecular Therapeutics
  • Joint Keynote Session for All Attendees to Meet/Share Ideas
  • More In-depth Pre-Conference Workshops
  • Lower Poster Pricing so You Can Share Your Research
  • Expanded Advisory Board of Industry Leaders
  • Simplified Registration and Conference Format

Oligonucleotide & Peptide Whitepapers


We take the time to create these whitepapers to help educate our audience about a particular topic and promote a best practice methodology. Consider these advanced problem-solving guides!

PRESENT A SCIENTIFIC POSTER AT TIDES Europe 2019


Highlight your company's latest research findings by presenting a scientific poster, which will be displayed in the Exhibit & Poster Hall during the event. The deadline to submit your poster presentation is October 27. We will continue to accept posters after this date, however, the presentation won't be listed in the event guide. 


Benefits of presenting a poster:

  1. FOCUSED DISCUSSIONS: Posters offer the opportunity to engage with others also interested in the same subject and application as yourself which could potentially lead to future collaboration.
  2. RECEIVE IMPARTIAL CRITIQUES: An insightful, impartial discussion of your work by a peer can often provide ideas for improving your work downstream.
  3. SHARPEN YOUR PRESENTATION SKILLS: Presenting a poster enables you to explain a concept in different ways to see which method is most well received and practice your visual and oral presentations.
  4. HONE YOUR IDEAS: A poster is ideal for early stages of the research, when you may not have much more than an idea, and you stand to benefit a lot from discussing your idea with other researchers from the same field.

TIDES Highlight Video


Are you curious as to what attending TIDES Europe is like?

See and hear for yourself why our attendees rank TIDES as the #1 meeting to gain the science, technologies and contacts they need to accelerate promising oligonucleotide and peptide products towards commercial success!

Find Your Next Partner at TIDES Europe 2019


All registered attendees receive access to our partnering tool, partneringONE®.

Benefits of partneringONE®:

  • Conduct more meetings at one conference than in the rest of the year
  • Contact existing and potential partners prior to the conference
  • Manage all your conference activities in one place
  • Your meetings will be prescheduled to maximize your time on site.

TIDES Europe 2019 Advisory Board

Special thank you to our expanded TIDES Europe Advisory Board, who helped bring new content and expertise to this year's conference agenda. 

Peptide Chemistry, Manufacturing and Controls
  • Mimoun Ayoub, Ph.D., Director and Head of North American and Emerging Markets, CordenPharma International, Switzerland
  • Fabrizio Badalassi, Ph.D., Director, Chemical Development, Ferring Pharmaceuticals, Denmark
  • Alastair Hay, Ph.D., Account Manager, Peptide and Protein Technology, Almac, United Kingdom
  • Ewa Kowalska, Chemical Process Development Manager, API Development, Ipsen Manufacturing Ireland Ltd.
  • Vivian Lindo, Head of Analytical Sciences & Associate Director, MedImmune, United Kingdom
  • Leila Malik, Ph.D., CMC Project Manager, Zealand Pharma AS, Denmark
  • Thomas Meier, COO Europe, Bachem AG, Switzerland
  • Neil Thompson, Group Commercial Director, PolyPeptide Group, Sweden
Peptide Discovery, Preclinical and Clinical
  • Waleed Danho, Ph.D., Consultant, Danho & Associates, USA
  • Jesse Z. Dong, Ph.D., Vice President, Peptide Chemistry, Neon Therapeutics, USA
  • Jesper Lau, Ph.D., VP, Protein and Peptide Chemistry, Global Research, Novo Nordisk A/S, Denmark
  • Les Miranda, Ph.D., Executive Director Research, Structural Biology, Molecular Modeling, & Hybrid Modality Engineering, Amgen, USA
  • Bruce Morimoto, Ph.D., Vice President, Drug Development-Operations, Alkahest, USA
Oligonucleotide Chemistry Manufacturing and Controls
  • Nadim Akhtar, Ph.D., Principal Scientist Characterization and Control Strategies, AstraZeneca, United Kingdom
  • Alun Garner, Business Development Manager, Nucleic Acid Solutions Division, Agilent Technologies, Inc., USA
  • Annekathrin Haberland, Ph.D., Director, Regulatory Affairs, Berlin Cures GmbH, Germany
  • Rachel Orr, GSK Associate Fellow, Enablement Manager, GlaxoSmithKline R&D, United Kingdom 
  • Thomas Rupp, Owner & Principal, Thomas Rupp Consulting, Germany
  • Yogesh Sanghvi, Ph.D., President, Rasayan, USA
  • Jessica Stolee, Ph.D., Associate Director, CMC, Biogen, USA
  • David Tew, Project Leader and GSK Senior Fellow, Advanced Manufacturing Technology, GlaxoSmithKline, United Kingdom
  • Sridhar Vaddeboina, Ph.D., Vice President , Analytical Development, Technology Innovation Improvement Management, Nitto Denko Avecia Inc., USA
  • Stefan Vonhoff, Ph.D., Vice President CMC, NOXXON Pharma AG, Germany
Oligonucleotide Discovery, Preclinical and Clinical
  • Troels Koch, Ph.D., Industry Expert, Denmark
  • Muthiah (Mano) Manoharan, Ph.D., Senior Vice President of Drug Discovery, Alnylam Pharmaceuticals, USA
  • Dmitry Samarsky, Ph.D., Chief Technology Officer, Sirnaomics, USA
  • Punit Seth, Ph.D., Vice President, Medicinal Chemistry, Ionis Pharmaceuticals
mRNA Therapeutics
  • Christoph Kröner, Ph.D., Head of IVAC Mutanome Lead Structure, BioNTech AG, Germany
  • Hari Pujar, Ph.D., Head, Technical Development, Moderna Therapeutics, USA
  • Liza Tritschler, Project Manager, CureVac AG, Germany

CONNECT WITH KEY BUYERS AT TIDES Europe 2019 in Amsterdam


Whether you're increasing your company profile, launching a new product or creating business development opportunities, we have flexible and tailored solutions that will optimize your investment.  Contact our team today to see a list of pricing and package options: 

(Companies A, R-Z) Perri Lucatello | Perri.Lucatello@knect365.com | +44 (20) 7017 7247

(Companies H, J-Q) Linda Cole | Linda.Cole@knect365.com | +44 (20) 7017 6631

(Companies B-G, I) Michael Dunnet | Michael.Dunnet@knect365.com | +1 (857) 504-6732